The China multi-center cohort study on risk evaluation of #ACM (ChinaCORE ACM) registry contributes to expanding the understanding of the disease spectrum of Chinese ACM patients and improving prognostic predictions. https://t.co/aDG4FfHRRt #ACCAsia #JACCAsia #ACCIntl https://t.co/AftL15LAmj
China Multi-Center Cohort Study on Risk Evaluation of Arrhythmogenic Cardiomyopathy: The ChinaCORE ACM Registry.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2025 – Jul 2025Where it's discussed
-
X / Twitter3 posts
-
YouTube2 videos
-
Facebook2 posts
AI synopsis
What people are saying
The discussions emphasize how the ChinaCORE ACM registry enhances understanding of Chinese patients with ACM and highlights its significance for prognosis, using positive language such as 'contributes to expanding' and 'improving.' The tone is supportive and focused on the study's potential to advance clinical practice and research in cardiomyopathy.
The discussions express support for the importance of the study in advancing understanding of ACM in China.
Posts show moderate interest, focusing on the study's contribution rather than technical details.
Participants reference the research's scope and potential benefits, indicating active engagement.
The discussions suggest the study is viewed as impactful for clinical prognosis and future research.
Abstract in brief
- The study focuses on arrhythmogenic cardiomyopathy (ACM) in China, highlighting the need for a specific prognostic model due to unique genetic and clinical characteristics.
- A national cohort has been established with 622 ACM patients and their family members, collecting comprehensive data such as medical history, ECGs, and imaging.
- Preliminary results show a high prevalence of arrhythmia symptoms and significant cardiac abnormalities, with substantial outcomes recorded, including malignant arrhythmias and heart failure cases, supporting the importance of this research.
Top posts
Most liked on X and BlueskyRT @JACCJournals: The China multi-center cohort study on risk evaluation of #ACM (ChinaCORE ACM) registry contributes to expanding the unde…
All mentions
ChinaCORE ACM Registry: Genetic and Clinical Insights in Arrhythmogenic Cardiomyopathy
JACC Asia Deputy Editor Dong Zhao MD and author Liang Chen MD PhD discuss Dr. Chen's work on a national multicenter cohort registry in China focused on arrhythmogenic cardiomyopathy ACM. The study highlights genetic…
ChinaCORE ACM Registry: Genetic and Clinical Insights into Arrhythmogenic Cardiomyopathy
This study highlights the need for a specific prognostic model for arrhythmogenic cardiomyopathy based on a national cohort of 622 patients, revealing high arrhythmia prevalence and significant cardiac abnormalities…
Brief Introduction - China Multi-Center Cohort Study on Risk Evaluation of Arrhythmogenic Cardiomyopathy (ChinaCORE ACM) Registry | JACC: Asia https://t.co/8EWa6N9BoR
RT @JACCJournals: The China multi-center cohort study on risk evaluation of #ACM (ChinaCORE ACM) registry contributes to expanding the unde…
The China multi-center cohort study on risk evaluation of #ACM (ChinaCORE ACM) registry contributes to expanding the understanding of the disease spectrum of Chinese ACM patients and improving prognostic predictions. https://t.co/aDG4FfHRRt #ACCAsia #JACCAsia #ACCIntl https://t.co/AftL15LAmj